Unilever, Phytopharm scuttling Hoodia deal

Another weight-loss product bites the dust: Phytopharm said Friday that it is in discussions with Unilever, its partner for the development of Hoodia extract as a functional food targeting weight management, with a view to mutually terminating their agreements. Release

Suggested Articles

Amarin Vascepa pill
Pharma

Amarin's Vascepa sails through FDA panel vote toward new CV nod

It's taken years for Amarin's Vascepa to prove itself as a game-changing treatment for CV disease. An FDA committee may have just punched its pass.

by Kyle Blankenship
Fujifilm Diosynth Biotechnologies in Texas
Manufacturing

Fujifilm investing $120M in U.S. gene therapy operations

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

by Eric Palmer
Falcon 9 launch
Marketing

Intercept amps up sales force ahead of potential NASH rollout

With a potential approval next year in the up-and-coming NASH field, Intercept is staffing up its sales team and starting talks with payers.

by Eric Sagonowsky